Friday 6 November 2026
Export AMN’s income statement to Excel — free account
AMN Healthcare Services Inc
AMN Healthcare Medical Care Facilities
AMN Healthcare Services Inc’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 8.49% from fiscal 2024.
- Revenue
- +13.1%
- EPS
- +11.8%
- Free cash flow
- −759.5%
- Total debt
- −18.9%
Quarter to September 2026, against a year earlier
36.15
11.27
−23.77%
Follow AMN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 7 | 7 |
| (14.19%) | (4.54%) | 15.56% | 15.36% | ||
| (4.24%) | (1.30%) | 4.59% | 4.92% | ||
ROIC |
(2.52%) | 3.44% | 11.13% | 24.41% | |
Return on Tangible Assets |
(91.91%) | (14.86%) | 48.55% | 43.70% | |
Average Days of Receivables |
57.56 | 47.20 | 45.13 | 0.00 | |
Free Cash Flow per Share |
6.07 | 18.16 | 11.20 | 8.36 | |
Free Cash Flow |
233.83 | 706.34 | 436.92 | 327.03 | |
Capital Expenditures |
(35.63) | (32.90) | (33.84) | (33.53) | |
| Other line items | |||||
Cash ROIC |
16.20% | 35.04% | 23.67% | 31.72% | |
Accounts Receivable Turnover |
5.82 | 7.36 | 7.88 | 0.00 | |
Accounts Payable Turnover |
11.30 | 12.58 | 13.45 | 13.95 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
30.22 | 29.12 | 28.44 | 27.53 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.05) | (4.52) | (0.36) | (0.36) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.72% | 19.41% | 19.12% | 18.97% | |
Share Based Compensation of Revenue |
1.12% | 0.91% | 0.94% | 0.97% | |
Interest Coverage |
(1.22) | 1.23 | 5.61 | 6.08 | |
Operating CF/Net income |
(2.82) | (22.78) | 4.49 | 3.31 | |
Depreciation/Fixed assets |
1.95 | 2.08 | 1.25 | 0.00 | |
Capex/Depreciation |
(0.13) | (0.13) | (0.23) | 0.00 | |
Revenue per Share |
70.88 | 87.89 | 88.01 | 89.93 | |
Operating CF per Share |
7.00 | 19.00 | 12.06 | 9.22 | |
Capex per Share |
(0.92) | (0.85) | (0.87) | (0.86) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 6 Nov 2026